Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 394 · page 1 of 5 of this heading
USE OF ANTIDEPRESSANT MEDICATIONS
(Updated 12/03/2025)
Antidepressants Protocol Expansion - Effective April 24, 2024:
Additional medications have been added as allowed for special issuance consideration,
representing an additional class of antidepressant medications beyond SSRIs. This change,
along with the addition of Wellbutrin (a Dopamine/Norepinephrine-Reuptake Inhibitor) on
05/31/2023, has resulted in the FAA’s SSRI Protocol being renamed the Antidepressant
Protocol.
PLEASE NOTE: All references to SSRIs, SSRI Protocol, or SSRI program in existing checklists,
worksheets, charts, or protocol pages in the AME Guide are considered encompassed in the
Antidepressant Protocol and include all conditionally approved medications.
If you are an AIRMAN taking an SSRI – see Airman Information - SSRI INITIAL Certification
If you are an ATCS taking an SSRI – see FAA ATCS How to Guide
The FAA has determined that pilots or FAA Air Traffic Control Specialists (FAA ATCS) requesting
medical certificates while being treated with one of several specific antidepressant medications may
be considered. The Authorization decision is made on a case-by-case basis. The AME may not
issue.
If the airman/FAA ATCS opts to discontinue use of the medication, the AME must notate in Block
60, Comments on History and Findings, on FAA Form 8500-8 and defer issuance. To reapply for
regular issuance, the applicant must be off the SSRI for a minimum of 60 days with a favorable
report from the treating physician indicating stable mood and no aeromedically significant side
effects. See SSRI Decision Path I
An individual may be considered for an FAA Authorization of a Special Issuance (SI) or Special
Consideration (SC) of a Medical Certificate (Authorization) if:
1.) The applicant has one of the following diagnoses:
• Major depressive disorder (mild to moderate) either single episode or recurrent episode;
• Dysthymic disorder;
• Adjustment disorder with depressed mood; or
• Any non-depression related condition for which the SSRI is used
2.) For a minimum of 3 continuous months prior, the applicant has been clinically stable
as well as on a stable dose of medication without any aeromedically significant side
effects and/or an increase in symptoms. If the applicant has been on the medication under 3
months, the AME must advise that 3 months of continuous use is required before SI/SC
consideration.
3.) The medication used is one of the conditionally acceptable Antidepressant Medications.
(single use only; not combined).
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
FAA Guide for Aviation Medical Examiners, Version 10/28/2026. AME Copilot is an independent reference tool, not affiliated with or endorsed by the FAA. The FAA AME Guide is the authoritative source. Types such as “Guide topic” are reading aids; AME Copilot does not make certification decisions.